CF gene repair study halted early: lab tests show promise but trial ends
NCT ID NCT05100823
First seen Nov 01, 2025 · Last updated Jun 08, 2026 · Updated 31 times
Summary
This study aimed to see if a special molecule (oligonucleotide blocker) could fix the genetic glitch in cells from people with cystic fibrosis. Researchers planned to test this on cells from 16 patients aged 12 and older. The trial was terminated early, so results are limited to lab findings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Montpellier University Hospital
Montpellier, 34090, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.